年龄相关性黄斑变性不可忽视的中医治疗选择
本文综述了中医药(含方剂、针灸和草药)治疗年龄相关性黄斑变性(AMD)的文献,梳理了中医对AMD的理论认识及常用中药的可能作用机制,认为中医药是AMD有前景的治疗选择,但缺乏严谨科学证据限制了其应用,未来应聚焦机制与活性成分研究。
要点
- 中医药(方剂、针灸、草药)已长期用于AMD治疗,是潜在治疗选择。
- 中医对AMD的理论解释为理解方剂和针灸效果提供了理论基础。
- 缺乏严谨科学证据是限制中医药疗法影响和推广的关键问题。
核心结论
- 中医药是AMD患者有前景的治疗选择,但缺乏严谨科学证据限制了其影响和推广。
研究设计与样本
- 综述检索了PubMed、Web of Science、Google Scholar和中国知网(CNKI)等数据库,并查阅相关书籍及博硕士论文。
主要发现
- 中医对AMD的解释为理解方剂和针灸效果建立了理论基础。
- 综述详细讨论了常用中药的可能作用机制。
临床怎么用
- 临床可考虑将中医药(方剂、针灸、草药)作为AMD的治疗选择之一。
- 应用时需注意现有证据尚缺乏严谨科学性。
局限性
- 缺乏严谨科学证据限制了中医药疗法的影响和推广。
- 未来研究应聚焦于理解中医药疗法的作用机制和活性成分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Age-related macular degeneration (AMD) is a chronic neurodegenerative disease which causes irreversible central vision loss among the elderly population. Traditional Chinese Medicine (TCM), including formulas, acupuncture and herbs, has been used in the treatment of AMD for thousands of years and is currently used by many AMD patients around the world. AIM OF THE REVIEW: A comprehensive, in-depth literature review examining the use of TCM in the treatment of AMD has yet to be compiled. This review will improve current knowledge relating to the use of TCM and will open new avenues of exploration in developing new drugs for the treatment of AMD. METHODS: A literature search of the PubMed database, Web of Science, Google Scholar and China National Knowledge Infrastructure (CNKI) was performed using relevant terms and keywords related to TCM in the treatment of AMD. Related books, PhD and master's theses were also researched. RESULTS: The TCM-based interpretation of AMD has been used to establish a theoretical foundation for understanding the effect of TCM formulas and acupuncture on AMD. The possible mechanism of action of common Chinese herbs has also been discussed in detail. CONCLUSION: TCM is a promising treatment option of AMD patients. However, lack of rigorous scientific evidence has limited the impact and uptake of TCM therapy. Future research should focus on improving understanding of the mechanism of action and bioactive components of TCM therapies.
引用
- Li Y, Li X, Li X, et al. Non-neglectable therapeutic options for age-related macular degeneration: A promising perspective from traditional Chinese medicine. J Ethnopharmacol. 2021. PMID: 34474141. doi:10.1016/j.jep.2021.114531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。